|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 813 studies with search of: | vaccination |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules
|
||||
| 2 | Active, not recruiting |
Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers
|
||||
| 3 | Recruiting |
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12
|
||||
| 4 | Recruiting |
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
|
||||
| 5 | Recruiting |
Characterization of Humoral and Cellular Immunity of Low and High-Responders After Tick-Borne Encephalitis (TBE) Vaccination
|
||||
| 6 | Active, not recruiting |
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
|
||||
| 7 | Completed |
Influenza Vaccination in the Emergency Department
|
||||
| 8 | Recruiting |
Study to Evaluate Impact of School-Based Influenza Vaccination on School Populations
|
||||
| 9 | Completed |
Efficacy Study of T Cell Vaccination in HIV Infection
|
||||
| 10 | Active, not recruiting |
Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
|
||||
| 11 | Completed |
Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients
|
||||
| 12 | Enrolling by invitation |
Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar®
|
||||
| 13 | Completed |
Safety and Tolerability of and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving Anti-HIV Treatment
|
||||
| 14 | Recruiting |
Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients
|
||||
| 15 | Completed |
Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
|
||||
| 16 | Recruiting |
TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
|
||||
| 17 | Completed |
Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study
|
||||
| 18 | Completed |
Long-Term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.
|
||||
| 19 | Completed |
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
|
||||
| 20 | Completed |
Influenza Vaccination and Oral Anticoagulant Therapy
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|